References: Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine

Views

CrossRef citations to date

Altmetric

References

Pantelis C, Barnes T RE. Drug strategies and treatment-resistant schizophrenia. Australian and New Zealand Journal of Psychiatry 1996; 30: 20–37
PubMed Web of Science ®Google Scholar
Copolov D L, Bell W R, Benson W J, Keks N A, Strazzeri D C, Johnson G F. Clozapine treatment in Australia: a review of haematological monitoring. Medical Journal of Australia 1998; 168: 495–497
PubMed Web of Science ®Google Scholar
Levin G M, DeVane C L. A review of cyclic antidepressant-induced blood dyscrasias. Annals of Pharmacotherapy 1992; 26: 378–383
PubMed Web of Science ®Google Scholar
Kando J C, Tohen M, Castillo J, Centorrino F. Concurrent use of clozapine and valproate in affective and psychotic disorders. Journal of Clinical Psychiatry 1994; 55: 255–257
PubMed Web of Science ®Google Scholar
Centorrino F, Baldessarini R J, Kando J, Frankenburg F R, Volpicelli S A, Puopolo P R, Flood J G. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. American Journal of Psychiatry 1994; 151: 123–125
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date